PharmaTimes August 8, 2024
Jen Brogan

The study predicted the development of conditions including Alzheimer’s and heart disease

Researchers from the University of Edinburgh, along with commercial collaborators Optima Partners and Biogen, have revealed that artificial intelligence (AI) insights can predict a person’s disease’s development a decade in advance.

Using AI and machine learning tools to identify protein patterns in the blood, researchers have been able to predict the development of conditions such as Alzheimer’s disease (AD), heart disease and type 2 diabetes (T2D) prior to diagnosis.

Combined, conditions including dementia, heart and circulatory disease and diabetes are estimated to affect nearly 13 million people living in the UK.

The study, published in Nature Aging and funded by Wellcome, analysed blood samples from the UK Biobank...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Patient / Consumer, Provider, Survey / Study, Technology, Trends
Google digs deeper into healthcare AI: 5 notes
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
How AI Has And Will Continue To Transform Healthcare
AI Translates Nature into New Medicines | StartUp Health Insights: Week of Nov 26, 2024
Building AI trust: The key role of explainability

Share This Article